Kolexia
Bruneau Julie
Anatomie et cytologie
Hôpital Necker Enfants Malades
Paris, France
154 Activités
425 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome T Mastocytose Hépatite Lymphome T périphérique Leucémies Syndromes lymphoprolifératifs Leucémie-lymphome à cellules T de l'adulte Maladies virales

Industries

Eusa Pharma
4 collaboration(s)
Dernière en 2022
Bouchara-Recordati
2 collaboration(s)
Dernière en 2023
Innate Pharma
2 collaboration(s)
Dernière en 2023
EXAFIELD
1 collaboration(s)
Dernière en 2021

Dernières activités

Study of Lacutamab in Peripheral T-cell Lymphoma: A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma
Essai Clinique (Innate Pharma)   04 décembre 2023
Prognostic Characterization of Advanced Mastocytosis Patients Treated with Midostaurin According to Diagnosis and Mutation-Adjusted Risk Score: A Nation-Wide Ceremast Study of 170 Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Blood advances   20 octobre 2023
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Haematologica   01 octobre 2023
Chronic Aichi Virus Infection As a Cause of Long-Lasting Multiorgan Involvement in Patients With Primary Immune Deficiencies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   24 août 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
The Journal of allergy and clinical immunology   24 août 2023
Quand les tumeurs pédiatriques et adultes se rejoignent. Réponses au pré-test
Annales de pathologie   01 juillet 2023
Quand les tumeurs pédiatriques et adultes se rejoignent. Pré-test
Annales de pathologie   01 juillet 2023
Brigatinib in patients with ALK-positive anaplastic large cell lymphoma who have failed brentuximab vedotin
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
KILT: A RANDOMIZED NON-COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023